Q1. With reference to the Unique Transaction Identifier (UTI) framework for OTC derivative transactions notified by the RBI in February 2026, consider the following statements: 1. The UTI is an alphanumeric code of up to 52 characters that incorporates the Legal Entity Identifier (LEI) of the generating entity. 2. The technical specifications of the UTI are aligned with the guidance issued jointly by the Committee on Payments and Market Infrastructures (CPMI) and the International Organization of Securities Commissions (IOSCO). 3. The Securities and Exchange Board of India (SEBI) is the regulator empowered to administer the UTI regime for OTC derivatives in India. 4. Where a reportable OTC derivative transaction is submitted to the CCIL Trade Repository without a UTI, the CCIL-TR itself shall generate the UTI for that transaction. Which of the statements given above are correctly identified?
- The UTI is an alphanumeric code of up to 52 characters that incorporates the Legal Entity Identifier (LEI) of the generating entity.
- The technical specifications of the UTI are aligned with the guidance issued jointly by CPMI and IOSCO.
- The Securities and Exchange Board of India (SEBI) is the regulator empowered to administer the UTI regime for OTC derivatives in India.
- Where a reportable OTC derivative transaction is submitted to the CCIL Trade Repository without a UTI, the CCIL-TR itself shall generate the UTI.
- A. 1, 2 and 4 only
- B. 1, 3 and 4 only
- C. 2 and 3 only
- D. 1, 2, 3 and 4